You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The team plans to begin development work at InterVenn Malaysia's laboratory at Technology Park Malaysia in Kuala Lumpur.
Ymir Genomics and OHSU will share in any value created by the biomarkers and will jointly publish and validate the biomarkers in a large-scale multi-center study.
Mawi's iSWAB line of biospecimen collection devices include its flagship iSWAB-DNA for the collection of long-fragment double-stranded DNA in buccal cells.
Proteintech said that the combined companies will better address growing challenges in single-cell analysis, super-resolution imaging, and multiplex assays.
The synbio company offers scale and lower costs in "massive" end markets, SVB Leerink analysts said, and could soon command an even more attractive valuation.
Under the deal, the companies will offer NRGene software for SNP set creation with AgriPlex's genotyping platform and data analysis software.
For the three months ended June 30, the firm reported revenues of $5.4 million, down from $6.3 million in the year-ago quarter and missing the consensus Wall Street estimate of $5.9 million.
The German diagnostics firm expects more than €80 million in 2020 revenues, driven by its recovering core business and its COVID-19 testing business.
Researchers uncovered rare, damaging mutations in genes involved in early brain development among 22 percent of 381 sporadic congenital hydrocephalus cases.
PathogenDx has developed a technology that detects pathogen DNA found on surfaces with applications in agriculture and clinical lab testing.
The agency issued a new draft decision memo, outlining various criteria it intends to apply when determining coverage for current and future blood-based CRC screening tests.
The US Department of Health and Human Services (HHS) said that it would use Fluidigm's saliva-based molecular SARS-CoV-2 test as part of a federal surge testing program.
Thermo Fisher's test is now authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens.
The assay does not require nucleic acid extraction or purification, unlike a LumiraDx SARS-CoV-2 test that received Emergency Use Authorization in August.
DNA Genotek's devices are used with SARS-CoV-2 tests from Clinical Reference Laboratory and P23 Labs, while Clinical Enterprises' kit is offered by Eurofins.
News items for the week of Oct. 12, 2020.
The first stage generated a range of tools and resources for studying the nucleus in time and space including publicly available datasets and software.
Using RNA and DNA sequencing to predict tumor site and detect gene alterations may allow patients with CUP to receive appropriate targeted treatment.
The aggressive subtype, uncovered by a team of researchers in Germany, may also be susceptible to targeted therapy that blocks interferon signaling.
Myriad Genetics' EndoPredict, Agendia's MammaPrint (distributed in Germany by PathoNext), and Veracyte's Prosigna will now be covered by public insurance.
The researchers analyzed nearly a dozen new samples from various regions of Vanuatu and different eras in combination with previously published samples.
The preventive genomics medicine firm said it will use the funds to strengthen its international expansion efforts and develop new technological capabilities.
The organizations will apply PacBio's HiFi sequencing to a rare disease cohort whose genomes have not yet yielded causal variants by other methods.
Novacyt said that the acquisition secures important intellectual property for its q16 and q32 rapid-PCR instruments for near-patient testing of COVID-19.
The UK is investing £33.6 million into a controversial human SARS-CoV-2 challenge study, according to Reuters.
The Guardian reports that the UK COVID genomics consortium is monitoring mutations that are arising within circulating SARS-CoV-2 strains for any that may affect future vaccines.
Science reports that Max Planck and Nature have struck a deal for affiliated authors to publish papers that are accessible to the public as well as access Nature-branded journals.
In PNAS this week: genomic analysis of ancient animals from Tibet, oncoproteins tied to WEE1 kinase enzyme inhibitor response, and more.